Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Trulieve Cannabis Corp.TRUL · Entity 4418 | Chief Technology Officer | March 13, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Trulieve Cannabis Corp.
Report date March 13, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Subordinate Voting SharesSEC Table I · non-derivative | Direct | 239,254 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Grant · Acquired 58,594 · Balance 239,254 F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.40 · Expires 2033-03-13 | Direct | 41,668 |
Reported balance
After 2026-03-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-13 · Grant · Acquired 41,668 · Balance 41,668 F2: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028. |
| Subordinate Voting SharesSEC Table I · non-derivative | IndirectBy Spouse | 7,000 |
Reported balance
Holding disclosure · report date 2026-03-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 7,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.
F2: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2026 Filed Mar 17, 2026 17:10 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | GrantStock Option (Right to Buy) · Derivative | 41,668 | $0.00 Strike: $6.40 | $0.00 |
DisclosureSEC source: 0002044797-26-000002 · primary_doc.xml · derivative · entry 3 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,668 Underlying: Subordinate Voting Shares · 41,668 shares Expires 2033-03-13 F2 · derivative.exercise_date: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 17:10 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | GrantSubordinate Voting Shares | 58,594 | $0.00 | $0.00 |
DisclosureSEC source: 0002044797-26-000002 · primary_doc.xml · nonDerivative · entry 1 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,254 F1 · shares: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028. Read SEC document |
| December 01, 2025 Filed Dec 8, 2025 16:56 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | Tax withholdingSubordinate Voting Shares | 18,041 | $5.39 | $97,240.99 |
DisclosureSEC source: 0002044797-25-000003 · primary_doc.xml · nonDerivative · entry 1 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,660 F1 · shares: Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2025, the grant of which RSUs to the reporting person were previously reported on Form 4. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 16:20 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | GrantSubordinate Voting Shares | 93,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001835207-25-000019 · primary_doc.xml · nonDerivative · entry 1 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,701 F1 · shares: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027. Read SEC document |
| March 25, 2025 Filed Mar 28, 2025 17:59 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | GrantStock Option (Right to Buy) · Derivative | 155,013 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001835207-25-000014 · primary_doc.xml · derivative · entry 1 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,013 Underlying: Subordinate Voting Shares · 155,013 shares Expires 2032-03-25 F1 · derivative.exercise_date: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2025, one-third vesting on December 1, 2026, and one-third vesting on December 1, 2027. Read SEC document |
| December 29, 2024 Filed Dec 31, 2024 17:07 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | Tax withholdingSubordinate Voting Shares | 2,126 | $4.78 | $10,162.28 |
DisclosureSEC source: 0001790300-24-000034 · primary_doc.xml · nonDerivative · entry 1 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,649 F1 · shares: Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 29, 2024, the grant of which RSUs to the reporting person were previously reported on Form 4. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 18:49 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | Tax withholdingSubordinate Voting Shares | 7,003 | $6.03 | $42,228.09 |
DisclosureSEC source: 0001790300-24-000026 · primary_doc.xml · nonDerivative · entry 1 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,775 F1 · shares: Represents shares withheld for payment of tax liability in connection with vesting of restricted stock units ("RSUs") on December 1, 2024, the grant of which RSUs to the reporting person were previously reported on Form 4. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 18:06 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | PurchaseSubordinate Voting Shares | 2,500 | $6.32 | $15,800.00 |
DisclosureSEC source: 0001790300-24-000009 · primary_doc.xml · nonDerivative · entry 4 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 6,000 Read SEC document |
| November 11, 2024 Filed Nov 14, 2024 18:06 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | PurchaseSubordinate Voting Shares | 2,000 | $5.70 | $11,400.00 |
DisclosureSEC source: 0001790300-24-000009 · primary_doc.xml · nonDerivative · entry 3 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 3,500 Read SEC document |
| November 08, 2024 Filed Nov 14, 2024 18:06 UTC | Trulieve Cannabis Corp. TRUL · Entity 4418 | PurchaseSubordinate Voting Shares | 1,500 | $6.98 | $10,470.00 |
DisclosureSEC source: 0001790300-24-000009 · primary_doc.xml · nonDerivative · entry 2 Jhala Nilyum · CIK 0002044797 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 1,500 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any securityholder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.